Drugs facing the most patent expirations this year

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities.

Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril from loss of patent protection.

This chart shows which pharmaceutical companies face the most patent expirations this year.

The drug companies facing the most patent expirations this year are:

• Takeda Pharms Usa
• Abbvie
• Novartis
• Bristol Myers Squibb
• Collegium Pharm Inc
• Auxilium Pharms Llc
• Purdue Pharma Lp
• Amgen Inc
• Astrazeneca
• Merck Sharp Dohme